COMP <GO>
KRMD vs LUNG // FREE CASH FLOW YIELD
KORU Medical Systems Inc. (NASDAQ) VS. Pulmonx Corporation (NASDAQ) • 15-METRIC TALLY: KRMD 8
— LUNG 2
▲ FREE CASH FLOW YIELD LEADER: KRMD
LAST: $2.99 (-7.43%) • MKT CAP: $149.1M
fcf-yield
0.31%
LAST: $3.01 (-5.05%) • MKT CAP: $135.9M
fcf-yield
-24.15%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (KRMD VS. LUNG)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | KRMD | LUNG | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 62.30% | 74.20% | -11.90 | LUNG | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -28.70% | -35.00% | +6.30 | KRMD | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield ACTIVE | 0.31% | -24.15% | +24.46 | KRMD | /fcf-yield <GO> |
| Operating Margin | -7.20% | -59.30% | +52.10 | KRMD | /operating-margins <GO> |
| Net Profit Margin | -6.40% | -59.70% | +53.30 | KRMD | /net-margins <GO> |
| Revenue Growth (YoY) | 22.20% | 8.00% | +14.20 | KRMD | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 8.05 | 0.20 | +7.85 | KRMD | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 6/9 | +1.00 | KRMD | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 55.8 | 79.1 | -23.30 | LUNG | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $149.1M | $135.9M | $13.2M | KRMD | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | KRMD REV | LUNG REV | KRMD GROSS % | LUNG GROSS % | KRMD FCF | LUNG FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $41.1M | $90.5M | 62.3% | 74.2% | $462.4K | -$32.8M |
| FY 2024 | $33.6M | $83.8M | 63.4% | 74.0% | -$319.7K | -$33.0M |
| FY 2023 | $28.5M | $68.7M | — | — | -$4.9M | -$37.6M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
KRMD // BETA —
LUNG // BETA —